Cesare Gridelli

Cesare Gridelli

UNVERIFIED PROFILE

Are you Cesare Gridelli?   Register this Author

Register author
Cesare Gridelli

Cesare Gridelli

Publications by authors named "Cesare Gridelli"

Are you Cesare Gridelli?   Register this Author

100Publications

2758Reads

5Profile Views

The New Immunotherapy Combinations in the Treatment of Advanced Non-Small Cell Lung Cancer: Reality and Perspectives.

Curr Clin Pharmacol 2019 Aug 9. Epub 2019 Aug 9.

Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574884714666190809124555DOI Listing
August 2019

Combining immunotherapies to treat non-small cell lung cancer.

Expert Rev Respir Med 2019 Jul 29;13(7):621-634. Epub 2019 May 29.

a Division of Medical Oncology , 'S. G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2019.1623027DOI Listing
July 2019

The role of combination chemo-immunotherapy in advanced non-small cell lung cancer.

Expert Rev Anticancer Ther 2019 Jul 25;19(7):561-568. Epub 2019 Jun 25.

c Division of Medical Oncology , "S.G. Moscati" Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2019.1631800DOI Listing
July 2019

Pneumonectomy in Stage IIIA-N2 NSCLC: Should It Be Considered After Neoadjuvant Chemotherapy?

Clin Lung Cancer 2019 03 24;20(2):97-106.e1. Epub 2018 Oct 24.

Division of Thoracic Surgery, European Institute of Oncology, University of Milan, Milan, Italy; University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15257304183026
Publisher Site
http://dx.doi.org/10.1016/j.cllc.2018.10.005DOI Listing
March 2019

First-line treatment of advanced non-small cell lung cancer with ALK rearrangement: state of the art and future development.

Expert Rev Respir Med 2019 Mar 28:1-7. Epub 2019 Mar 28.

c Division of Medical Oncology , 'S.G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2019.1600824DOI Listing
March 2019

Safety and Tolerability of Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer.

Drug Saf 2019 02;42(2):199-209

Division of Medical Oncology, "S.G. Moscati" Hospital, Contrada Amoretta, 83100, Avellino, Italy.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s40264-018-0771-y
Publisher Site
http://dx.doi.org/10.1007/s40264-018-0771-yDOI Listing
February 2019

Advanced Non-Small Cell Lung Cancer with Activating Epidermal Growth Factor Receptor Mutation: First Line Treatment and Beyond.

Rev Recent Clin Trials 2019 ;14(2):120-128

Division of Medical Oncology, AORN Giuseppe Moscati, Avellino, Italy.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/168096/article
Publisher Site
http://dx.doi.org/10.2174/1574887114666181205155211DOI Listing
January 2019

The combination strategies will be ready the right first-line choice for squamous lung cancer patients?

Transl Lung Cancer Res 2018 Dec;7(Suppl 4):S349-S351

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.11.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328703PMC
December 2018

Immunotherapies in the management of epidermal growth factor receptor mutated non-small cell lung cancer: a role will be found?

Transl Lung Cancer Res 2018 Dec;7(Suppl 4):S370-S372

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2018.09.18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6328693PMC
December 2018

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2027-2039. Epub 2018 Sep 25.

From the University of Colorado Cancer Center, Aurora (D.R.C.); Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine (H.R.K.), Samsung Medical Center (M.-J.A.), and Seoul National University Hospital (D.-W.K.), Seoul, National Cancer Center, Goyang (J.-Y.H.), Seoul National University Bundang Hospital, Seongnam (J.-S.L.), and Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.) - all in South Korea; National Taiwan University Hospital (J.C.-H.Y.) and the Faculty of Medicine, School of Medicine, National Yang-Ming University (G.-C.C.), Taipei, and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung (G.-C.C.) - all in Taiwan; the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna (M.J.H.); Queen Elizabeth Hospital, Kowloon, Hong Kong (J.Y.-C.L.); Azienda Ospedaliera S. Giuseppe Moscati, Avellino (C.G.), the Scientific Institute of Romagna for the Study and Treatment of Cancer, Meldola (A.D.), Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS Struttura Operativa Complessa Oncologia Medica A, Aviano (A.B.), Thoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples (A.M.), and the Medical Oncology Unit, University Hospital of Parma, Parma (M.T.) - all in Italy; Complejo Hospitalario Universitario de A Coruña, Coruña (R.G.C.), and Vall d'Hebron University Hospital, Barcelona (E.F.) - both in Spain; the Department of Hematology and Oncology, University Department of Internal Medicine-Oncology, Pius-Hospital Medical Campus, University of Oldenburg, Oldenburg, Germany (F.G.); the Department of Medical Oncology, Christie NHS Foundation Trust, and Division of Cancer Sciences, University of Manchester, Manchester (R.C.), and Guy's and St. Thomas' NHS Foundation Trust (S.G.) and Royal Marsden Hospital and the National Heart and Lung Institute, Imperial College London (S.P.), London - all in the United Kingdom; Virginia Cancer Specialists Research Institute and US Oncology Research, The Woodlands, TX (A.S.); Yale Cancer Center, New Haven, CT (S.N.G.); and Millennium Pharmaceuticals, Cambridge, MA (N.G., J.H., D.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810171DOI Listing
November 2018

Frontline immunotherapy for NSCLC: alone or not alone?

Nat Rev Clin Oncol 2018 10;15(10):593-594

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0070-7DOI Listing
October 2018

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials.

J Clin Oncol 2018 09 20;36(25):2585-2592. Epub 2018 Jul 20.

Cesare Gridelli and Paolo Maione, Azienda Ospedaliera (AO) San Giuseppe Moscati, Avellino; Alessandro Morabito, Raffaele Costanzo, Gaetano Rocco, Gennaro Daniele, Maria Carmela Piccirillo, and Francesco Perrone, Istituto Nazionale Tumori, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) -Fondazione G. Pascale; Fortunato Ciardiello, Simona Signoriello and Ciro Gallo, Università degli Studi della Campania Luigi Vanvitelli; Roberto Bianco, Università degli Studi di Napoli Federico II; Ferdinando Riccardi, Azienda Ospedaliera di Rilievo Nazionale Cardarelli, Naples; Luigi Cavanna, Ospedale di Piacenza, Piacenza; Andrea Luciani, Ospedale S. Paolo; Virginio Filipazzi, Ospedale L. Sacco, Polo Universitario, Milan; Andrea Luciani and Silvana Leo, Gruppo Italiano di Oncologia Geriatrica; Manlio Mencoboni, Ospedale Villa Scassi, Azienda Sanitaria Locale 3 Genovese, Genoa; Laura Bonanno, Istituto Oncologico Veneto, IRCCS, Padova; Silvana Leo, AO Vito Fazzi, Lecce; Saverio Cinieri, Ospedale Senatore Antonio Perrino, Brindisi; Marco Angelo Burgio, Istituto Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola; Domenico Bilancia, AO San Carlo, Potenza; Diego Cortinovis, Ospedale San Gerardo, Monza; Francesco Rosetti, Mirano Unità Locale Socio Sanitaria 3, Serenissima Regione Veneto, Mirano; Vittorio Gebbia, Casa di Cura La Maddalena Università di Palermo, Palermo; Fabrizio Artioli, Ospedale Ramazzini di Carpi e Ospedale di Mirandola, Carpi; Roberto Bordonaro, AO Garibaldi Nesima, Catania; Vittorio Fregoni, Istituti Clinici Scientifici Maugeri, Pavia; Fabrizio Nelli, Ospedale Belcolle, Viterbo; and Giuditta di Isernia, Ospedale S. Giovanni Calibita Fatebenefratelli, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.76.8390DOI Listing
September 2018

Treatment of advanced non-small cell lung cancer in the elderly.

Expert Rev Respir Med 2018 09 21;12(9):783-792. Epub 2018 Aug 21.

a Division of Medical Oncology , "S.G.Moscati" Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17476348.2018.1510322DOI Listing
September 2018

What pharmacotherapeutics should one use for early stage non-small cell lung cancer?

Expert Opin Pharmacother 2018 09 16;19(13):1403-1406. Epub 2018 Aug 16.

c Hematology and Oncology Department , AORN Giuseppe Moscati , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2018.1510915DOI Listing
September 2018

Evolution in the treatment landscape of non-small cell lung cancer with ALK gene alterations: from the first- to third-generation of ALK inhibitors.

Expert Opin Emerg Drugs 2018 09 15;23(3):231-241. Epub 2018 Oct 15.

a Division of Medical Oncology , 'S. G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
https://www.tandfonline.com/doi/full/10.1080/14728214.2018.1
Publisher Site
http://dx.doi.org/10.1080/14728214.2018.1527902DOI Listing
September 2018

Lung cancer resection in octogenarian patients.

J Thorac Dis 2018 Jun;10(Suppl 17):S1995-S1997

Division of Medical Oncology, 'S. G. Moscati' Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.05.39DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036035PMC
June 2018

Lung cancer, elderly and immune checkpoint inhibitors.

J Thorac Dis 2018 May;10(Suppl 13):S1474-S1481

Division of Medical Oncology, 'S. G. Moscati' Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.05.90DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994497PMC
May 2018

The Combination of New Immunotherapy and Radiotherapy: A N ew Potential Treatment for Locally Advanced Non-Small Cell Lung Cancer.

Curr Clin Pharmacol 2017 ;12(1):4-10

Division of Medical Oncology, "S.G. Moscati" Hospital, Citta Ospedaliera, Contrada Amoretta, 83100 Avellino, Italy.

View Article

Download full-text PDF

Source
http://www.eurekaselect.com/147854/article
Publisher Site
http://dx.doi.org/10.2174/1574884711666161201123439DOI Listing
April 2018

Overcoming Resistance to EGFR Inhibitors in NSCLC.

Rev Recent Clin Trials 2016 ;11(2):99-105

Paolo Maione, MD, Division of Medical Oncology, "S. G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1574887111666160330120431DOI Listing
March 2018

Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitors.

Expert Rev Anticancer Ther 2018 01 6;18(1):71-80. Epub 2017 Dec 6.

a Division of Medical Oncology , 'S. G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2018.1412260DOI Listing
January 2018

The reproducibility of PD-L1 scoring in lung cancer: can the pathologists do better?

Transl Lung Cancer Res 2017 Dec;6(Suppl 1):S74-S77

Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.10.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5750142PMC
December 2017

Recent advances in targeted advanced lung cancer therapy in the elderly.

Expert Rev Anticancer Ther 2017 09 4;17(9):787-797. Epub 2017 Jul 4.

b Medical Oncology, S.G. Moscati Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737140.2017.1348232DOI Listing
September 2017

An update on the developing mitotic inhibitors for the treatment of non-small cell carcinoma.

Expert Opin Emerg Drugs 2017 09;22(3):213-222

a Division of Medical Oncology , 'S.G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728214.2017.1369952DOI Listing
September 2017

Selumetinib for the treatment of non-small cell lung cancer.

Expert Opin Investig Drugs 2017 Aug 12;26(8):973-984. Epub 2017 Jul 12.

a Division of Medical Oncology , 'S. G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13543784.2017.1351543DOI Listing
August 2017

The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly.

Expert Opin Biol Ther 2017 05 20;17(5):565-571. Epub 2017 Feb 20.

a Division of Medical Oncology , 'S. G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14712598.2017.1294157DOI Listing
May 2017

Alternative imaging strategy of solitary pulmonary nodule by FDG PET/CT: Can be imagined a tailored PET?

Eur J Radiol 2017 May 7;90:188-191. Epub 2017 Mar 7.

Department of Advanced Biomedical Sciences, University of Naples Federico II, Napoli, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2017.03.001DOI Listing
May 2017

The safety of second-line treatment options for non-small cell lung cancer.

Expert Opin Drug Saf 2017 Apr 1;16(4):471-479. Epub 2017 Mar 1.

a Division of Medical Oncology , S.G. Moscati Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2017.1297795DOI Listing
April 2017

Developments in pharmacotherapy for treating metastatic non-small cell lung cancer.

Expert Opin Pharmacother 2017 Feb 20;18(2):151-163. Epub 2017 Jan 20.

a Division of Medical Oncology , 'S.G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14656566.2017.1280460DOI Listing
February 2017

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy.

Support Care Cancer 2017 01 24;25(1):85-92. Epub 2016 Aug 24.

Division of Medical Oncology, San Giuseppe Moscati Hospital, Condtrada Amoretta, 8, Avellino, 83100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00520-016-3388-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127871PMC
January 2017

Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.

Anticancer Drugs 2017 01;28(1):104-109

aDivision of Medical Oncology, Department of Uro-Gynaecological Oncology 'Istituto Nazionale Tumori' 'Fondazione G. Pascale'-IRCCS bUnit of Epidemiology, 'Istituto Nazionale Tumori' 'Fondazione G. Pascale' - IRCCS cDivision of Medical Oncology, 'San Gennaro dei Poveri' Hospital, Naples dDepartment of Onco-Ematology and Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto eDivision of Medical Oncology, 'San Giuseppe Moscati' Hospital, Avellino fDivision of Medical Oncology, 'Gaetano Rummo' Hospital, Benevento gDepartment of Medical Oncology, National Cancer Institute, Aviano, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CAD.0000000000000428DOI Listing
January 2017

Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell Lines.

Anticancer Res 2016 11;36(11):5827-5833

Institute of Food Sciences, National Research Council, Avellino, Italy

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11167DOI Listing
November 2016

Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer.

Expert Rev Clin Pharmacol 2016 6;9(3):419-28. Epub 2016 Feb 6.

a Division of Medical Oncology , "S. G. Moscati" Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17512433.2016.1133289DOI Listing
October 2016

Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma.

Appl Immunohistochem Mol Morphol 2016 10;24(9):e86-e88

*Pathology Unit †Medical Oncology Unit, Department of Thoracic Surgical and Medical Oncology §Department of Thoracic Surgical and Medical Oncology, Division of Thoracic Surgery, Istituto Nazionale dei Tumori "Fondazione G. Pascale"-IRCCS ∥Department of Oncology and Anatomic Pathology, Hospital of National Relevance (AORN) Vincenzo Monaldi ¶Pathology Unit, Department of Psychiatry, University of Naples SUN, Naples ‡Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAI.0000000000000328DOI Listing
October 2016

Optimal drugs for second-line treatment of patients with small-cell lung cancer.

Expert Opin Pharmacother 2016 29;17(7):969-76. Epub 2016 Feb 29.

a Division of Medical Oncology , 'S.G. Moscati' Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1154539DOI Listing
September 2016

Current challenges of lung cancer care in an aging population.

Expert Rev Anticancer Ther 2015 15;15(12):1419-29. Epub 2015 Oct 15.

a 1 Division of Medical Oncology, 'S. G.Moscati' Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1096201DOI Listing
July 2016

Pharmacotherapeutic options for treating adverse effects of Cisplatin chemotherapy.

Expert Opin Pharmacother 2016 17;17(4):561-70. Epub 2015 Dec 17.

a Division of Medical Oncology , S.G. Moscati Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2016.1122757DOI Listing
July 2016

Agents in the preclinical development stage for non-small cell lung cancer.

Expert Rev Anticancer Ther 2015 20;15(11):1361-6. Epub 2015 Oct 20.

a ¹ Division of Medical Oncology, S. G. Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.2015.1092875DOI Listing
June 2016

Anti-EGFR and antiangiogenic monoclonal antibodies in metastatic non-small-cell lung cancer.

Expert Opin Biol Ther 2016 06 22;16(6):747-58. Epub 2016 Mar 22.

b Division of Medical Oncology , S.G. Moscati Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2016.1163333DOI Listing
June 2016

Safety profiles of first-line therapies for metastatic non-squamous non-small-cell lung cancer.

Expert Opin Drug Saf 2016 Jun 12;15(6):837-51. Epub 2016 Apr 12.

b Division of Medical Oncology , S.G. Moscati Hospital , Avellino , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14740338.2016.1170116DOI Listing
June 2016

The role of pembrolizumab in the treatment of advanced non-small cell lung cancer.

Ann Transl Med 2016 Jun;4(11):215

1 Division of Medical Oncology, "S. G. Moscati" Hospital, Contrada Amoretta 83100, Avellino, Italy ; 2 Division of Medical Oncology, "ULSS 15 Cittadella", via Casa di ricovero, 40 35013 Cittadella, Padova, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/atm.2016.05.64DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916358PMC
June 2016

Treatment of limited-stage small cell lung cancer in the elderly, chemotherapy vs. sequential chemoradiotherapy vs. concurrent chemoradiotherapy: that's the question.

Transl Lung Cancer Res 2016 Apr;5(2):150-4

1 Division of Medical Oncology, "S. G. Moscati" Hospital, Avellino, Italy ; 2 Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy ; 3 Clinical Engineering Unit, 4 Division of Radiotherapy, "S. G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2016.03.03DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858581PMC
April 2016

Novel cytotoxic drugs in advanced nonsmall cell lung cancer.

Curr Opin Oncol 2016 Mar;28(2):110-4

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCO.0000000000000266DOI Listing
March 2016

Necitumumab for the treatment of stage IV metastatic squamous non-small-cell lung cancer.

Expert Rev Respir Med 2015 Jun 22;9(3):245-54. Epub 2015 Mar 22.

Division of Medical Oncology, "S.G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17476348.2015.1027688DOI Listing
June 2015

Non-small-cell lung cancer.

Nat Rev Dis Primers 2015 05 21;1:15009. Epub 2015 May 21.

Catalan Institute of Oncology, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrdp20159
Publisher Site
http://dx.doi.org/10.1038/nrdp.2015.9DOI Listing
May 2015

[PARAMOUNT trial: clinical meaning of continuous maintenance therapy in lung cancer].

Authors:
Cesare Gridelli

Recenti Prog Med 2015 May;106(5):227-33

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1701/1868.20408DOI Listing
May 2015

Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials.

J Clin Oncol 2015 Mar 26;33(8):910-5. Epub 2015 Jan 26.

Massimo Di Maio, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Nuzzo, Andrea de Matteis, Jane Bryce, Alessandro Morabito, Gaetano Rocco, and Francesco Perrone, Istituto Nazionale Tumori-Fondazione "G. Pascale" Istituto di Ricovero e Cura a Carattere Scientifico; Ciro Gallo, Fortunato Ciardiello, and Simona Signoriello, Second University; Sabino De Placido, Federico II University, Napoli; Cesare Gridelli, S.G. Moscati Hospital, Avellino; Vittorio Gebbia, Istituto La Maddalena, Palermo; Anna Ceribelli, Regina Elena National Cancer Institute, Roma; Adolfo G. Favaretto, Istituto Oncologico Veneto, Padova, Italy; Natasha B. Leighl and Ronald Feld, Princess Margaret Hospital/University Health Network, Toronto; and Charles Butts, Cross Cancer Institute, Edmonton, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9334DOI Listing
March 2015

Emerging drugs targeting PD-1 and PD-L1: reality or hope?

Expert Opin Emerg Drugs 2014 Dec 25;19(4):557-69. Epub 2014 Sep 25.

Second University of Naples, Department of Clinical and Experimental Medicine , Naples , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728214.2014.964682DOI Listing
December 2014

ALK rearrangement testing by FISH analysis in non-small-cell lung cancer patients: results of the first italian external quality assurance scheme.

J Thorac Oncol 2014 Oct;9(10):1470-6

*Center of Predictive Molecular Medicine, Center of Excellence on Aging, University-Foundation, Chieti, Italy; †Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy; ‡Division of Anatomic Pathology, San Luigi Hospital and University of Turin, Orbassano, Italy; §Pathology Department, Policlinico di Modena, Modena, Italy; ‖Diagnostic and Laboratory Medicine, INT-Fondazione "G.Pascale", Naples, Italy; ¶Medical Oncology Unit, University Hospital, Parma, Italy; #Department of Medical Oncology, Perugia Hospital, Perugia, Italy; **Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy; ††Department of Human Pathology and Oncology, University of Florence, Florence, Italy; ‡‡Pathology Department, Casa di Cura San Pio X and I.R.C.C.S. Policlinico San Donato, Milano, Italy; §§Thoracic Oncology Unit, University of Torino, San Luigi Hospital, Torino, Italy; ‖‖Cell Biology and Biotherapy Unit, INT-Fondazione "G.Pascale", Naples, Italy; and ¶¶Medical Oncology Unit, S. Orsola-Malpighi Hospital, Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000280DOI Listing
October 2014

Diagnostic and therapeutic issues for patients with advanced non‑small cell lung cancer harboring anaplastic lymphoma kinase rearrangement: European vs. US perspective (review).

Int J Oncol 2014 Aug 21;45(2):509-15. Epub 2014 May 21.

Division of Medical Oncology, San Giuseppe Moscati Hospital, I-83100 Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2014.2453DOI Listing
August 2014

Final efficacy and safety results of pemetrexed continuation maintenance therapy in the elderly from the PARAMOUNT phase III study.

J Thorac Oncol 2014 Jul;9(7):991-7

*Division of Medical Oncology, S. Giuseppe Moscati Hospital, Avellino, Italy; †Department of Lung Diseases, San Camillo Hospital, Rome, Italy; ‡Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg, Germany; §Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India; ‖Centre Catherine De Sienne, Nantes, France; ¶Christie Hospital NHS Foundation Trust, Manchester, England; #CHR La Citadelle, Liege, Belgium; **Centre Hospitalier Regional Universitaire de Montpellier, Montpellier, France; ††Eli Lilly and Company, Indianapolis, IN; ‡‡Eli Lilly and Company, Madrid, Spain; §§Eli Lilly and Company, Neuilly-sur-Seine Cedex, France; ‖‖Eli Lilly and Company, Houten, The Netherlands; and ¶¶University Hospital, Virgen del Rocio, Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000207DOI Listing
July 2014

Cetuximab in advanced non-small cell lung cancer (NSCLC): the showdown?

J Thorac Dis 2014 Jun;6(6):578-80

1 Department of Clinical and Experimental Medicine, Second University of Naples, Naples, Italy ; 2 Division of Medical Oncology, "S. G. Moscati" Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2014.06.14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4073354PMC
June 2014

Phase II randomized study of vandetanib plus gemcitabine or gemcitabine plus placebo as first-line treatment of advanced non-small-cell lung cancer in elderly patients.

J Thorac Oncol 2014 May;9(5):733-7

*Division of Medical Oncology, "SG Moscati" Hospital, Avellino, Italy; †Department of Oncology, University of Turin, AOU San Luigi Orbassano, Turin, Italy; ‡Medical Oncology 1, "Fondazione IRCCS Istituto Nazionale dei Tumori", Milan, Italy; §Department of Oncology, San Paolo Hospital, Milan, Italy; ‖Second Medical Oncology Unit, "Istituto Oncologico Veneto", Padua, Italy; ¶European Institute of Oncology, Milan, Italy; #Department of Oncology, IRCCS Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.), Meldola (FC), Italy; **Division of Medical Oncology, S. Maria della Misericordia Hospital, Perugia, Italy; ††Lung Cancer Unit, National Institute for Cancer Research, Genoa, Italy; ‡‡Medical Oncology Department, Santa Chiara Hospital, Trento, Italy; §§Medical Oncology Unit, San Vincenzo Hospital, Taormina, Catania, Italy; ‖‖Oncology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy; ¶¶Medical Oncology Department, AUSL Bologna, Italy; ##Medical Oncology Unit, "Giovanni Paolo II" National Cancer Centre, Bari, Italy; ***Department of Oncology, Azienda Ospedaliera Treviglio, Treviglio (BG), Italy; †††Department of Oncology, University Hospital of Udine, Udine, Italy; ‡‡‡Department of Oncology, Ospedale Niguarda Ca' Granda, Milan, Italy; §§§AstraZeneca, Basiglio (MI), Italy; ‖‖‖LB Research, Cantù (CO), Italy; and ¶¶¶Medical Oncology, Second University of Naples, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000120DOI Listing
May 2014

PARAMOUNT: Descriptive subgroup analyses of final overall survival for the phase III study of maintenance pemetrexed versus placebo following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer.

J Thorac Oncol 2014 Feb;9(2):205-13

*Department of Thoracic Oncology, Lungen Clinic Großhansdorf, Großhansdorf, Germany; †Instituto de Biomedicina de Sevilla, University Hospital Virgen del Rocío, CSIC and Seville University, Seville, Spain; ‡San Camillo-Forlanini Hospital, Rome, Italy; §Le Mans Regional Hospital, Le Mans, France; ‖Jawaharlal Nehru Cancer Hospital and Research Center, Bhopal, India; ¶University Medical Center Hamburg-Eppendorf, Hamburg, Germany; #Eli Lilly and Company, Indianapolis, Indiana; **Eli Lilly and Company, Houten, The Netherlands; and ††Division of Medical Oncology, San Giuseppe Moscati Hospital, Avellino, Italy.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153019
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000076DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132027PMC
February 2014